Awardee OrganizationHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
Abstract
It became well known that the immune suppressive niche inside the tumor microenvironment
(TME) accounts for tumor immune escape and progression, in which the regulatory T cells (Tregs)
play an important role. Although some progress has been made in identifying transcriptional and
epigenetic events in Treg functional regulation in TME, a fundamental gap remains in our
understanding the detailed epigenetic networks mediating Treg survival, expansion and
enhanced immune suppressive function induced by TME. Vacuolar protein sorting 72 homolog
(VPS72), a histone chaperone that recognizes and exchanges histone H2A.Z for standard histone
H2A, has been shown in in vitro studies that regulate gene transcriptions especially related in
mitochondrial metabolism through chromatin remodeling, although the in vivo biological function
of VPS72 remains unknown. Our preliminary studies revealed the higher expression and positive
correlation between VPS72 and Foxp3 in the Tregs inside the TME. Intriguingly, our Treg-specific
VPS72 KO and H2A.Z KO mouse models showed normal thymic Treg development, but
dramatically interrupted peripheral Treg maintenance and function. These results led to our
central hypothesis that VPS72 is a critical epigenetic factor that can be induced by TME factors
and enhance Treg stability and function through H2A.Z chromatin remodeling of Treg in the TME.
In the proposed studies, we are using Treg-specific constitutive and inducible gene deletion
mouse models to determine the role of VPS72 and H2AZ in peripheral Treg cell maintenance,
stability and function in the cancer. Using combined scRNA-seq, scATAC-seq, and CUT & RUN-
seq multi-omic analysis, we will delineate the epigenetic strategies and detailed molecular
mechanisms and signaling pathways VPS72 used in controlling Treg homeostasis and function.
In transplant and spontaneous melanoma tumor models, we will evaluate the anti-tumor effects
of VPS72 and H2AZ suppression. Furthermore, TME factors and related molecular mechanisms
in upregulating VPS72 expression of Tregs in TME will be also investigated. Results from the
proposed study will not only enhance our understanding of Treg biology but will also facilitate the
development of more efficient Treg-based intervention strategies for cancer treatment.
Public Health Relevance Statement
Narrative
It became well known that the immune suppressive niche inside the tumor microenvironment (TME) accounts
for tumor immune escape and progression, in which the regulatory T cells (Tregs) play an important role.
Vacuolar protein sorting 72 homolog (VPS72), a histone chaperone that recognizes and exchanges histone
H2A.Z for standard histone H2A. In the proposed studies, we will use gene deletion mouse models to determine
the role of VPS72 and H2AZ in Treg cell maintenance, stability, and function in the tumor. Results from the
proposed study will not only enhance our understanding of Treg biology but will also facilitate the development
of more efficient Treg-based intervention strategies for cancer treatment.
No Sub Projects information available for 5R01CA284740-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA284740-02
Patents
No Patents information available for 5R01CA284740-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA284740-02
Clinical Studies
No Clinical Studies information available for 5R01CA284740-02
News and More
Related News Releases
No news release information available for 5R01CA284740-02
History
No Historical information available for 5R01CA284740-02
Similar Projects
No Similar Projects information available for 5R01CA284740-02